NCT02627859

26 Week Open Label Study Evaluating Single IA Injection of DUROLANE SJ for Treatment of Osteoarthritis Pain of the Ankle

A 26 Week Multicenter Prospective Open Label Clinical Study Evaluating a Single Intra-articular Injection of DUROLANE SJ1ml for Treatment of OA Pain of the Ankle

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 37 (actual)
• Sponsor: Bioventus LLC · Industry
• Sex: All
• Age: 19 Years – 85 Years
• Healthy volunteers: Not accepted

Summary

26 week open label study of treatment with Durolane for OA pain of the ankle

Detailed description

Single injection Durolane in patients with mild to moderate OA of the ankle.

Conditions

• Osteoarthritis

Interventions

Type	Name	Description
DEVICE	Durolane SJ	1ml single intra-articular injection in ankle

Timeline

• Start date: 2014-06-01
• Primary completion: 2016-08-01
• Completion: 2016-10-01
• First posted: 2015-12-11
• Last updated: 2016-09-21

Locations

1 site across 1 country: Canada